Cargando…
Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study
Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA that temporarily inhibits p53-mediated cell death that underlies AKI. METHODS: This prospective, mul...
Autores principales: | Thielmann, Matthias, Corteville, David, Szabo, Gabor, Swaminathan, Madhav, Lamy, Andre, Lehner, Lukas J., Brown, Craig D., Noiseux, Nicolas, Atta, Mohamed G., Squiers, Elizabeth C., Erlich, Shai, Rothenstein, Daniel, Molitoris, Bruce, Mazer, C. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487715/ https://www.ncbi.nlm.nih.gov/pubmed/34474590 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.053029 |
Ejemplares similares
-
Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury
por: Demirjian, Segav, et al.
Publicado: (2017) -
Impact of early quantitative morbidity on 1-year outcomes in coronary artery bypass graft surgery
por: Hébert, Mélanie, et al.
Publicado: (2021) -
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)
por: Mazer, C David, et al.
Publicado: (2023) -
Interfering with transmission
por: Wack, Andreas
Publicado: (2018) -
Interfering with Colds
Publicado: (2013)